|
1
|
Brenner H, Kloor M and Pox CP: Colorectal
cancer. Lancet. 383:1490–1502. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jin R, Liu W, Menezes S, Yue F, Zheng M,
Kovacevic Z and Richardson DR: The metastasis suppressor NDRG1
modulates the phosphorylation and nuclear translocation of
β-catenin through mechanisms involving FRAT1 and PAK4. J Cell Sci.
127:3116–3130. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Miyoshi N, Yamamoto H, Mimori K, Yamashita
S, Miyazaki S, Nakagawa S, Ishii H, Noura S, Ohue M, Yano M, et al:
ANXA9 gene expression in colorectal cancer: A novel marker for
prognosis. Oncol Lett. 8:2313–2317. 2014.PubMed/NCBI
|
|
4
|
Persson H, Kvist A, Rego N, Staaf J,
Vallon-Christersson J, Luts L, Loman N, Jonsson G, Naya H, Hoglund
M, et al: Identification of new microRNAs in paired normal and
tumor breast tissue suggests a dual role for the ERBB2/Her2 gene.
Cancer Res. 71:78–86. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sasahira T, Kurihara M, Bhawal UK, Ueda N,
Shimomoto T, Yamamoto K, Kirita T and Kuniyasu H: Downregulation of
miR-126 induces angiogenesis and lymphangiogenesis by activation of
VEGF-A in oral cancer. Br J Cancer. 107:700–706. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ueno K, Hirata H, Shahryari V, Deng G,
Tanaka Y, Tabatabai ZL, Hinoda Y and Dahiya R: MicroRNA-183 is an
oncogene targeting Dkk-3 and SMAD4 in prostate cancer. Br J Cancer.
108:1659–1667. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ferraro A, Kontos CK, Boni T, Bantounas I,
Siakouli D, Kosmidou V, Vlassi M, Spyridakis Y, Tsipras I, Zografos
G and Pintzas A: Epigenetic regulation of miR-21 in colorectal
cancer: ITGB4 as a novel miR-21 target and a three-gene network
(miR-21-ITGβ4-PDCD4) as predictor of metastatic tumor potential.
Epigenetics. 9:129–141. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sun D, Yu F, Ma Y, Zhao R, Chen X, Zhu J,
Zhang CY, Chen J and Zhang J: MicroRNA-31 activates the RAS pathway
and functions as an oncogenic MicroRNA in human colorectal cancer
by repressing RAS p21 GTPase activating protein 1 (RASA1). J Biol
Chem. 288:9508–9518. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen DL, Wang DS, Wu WJ, Zeng ZL, Luo HY,
Qiu MZ, Ren C, Zhang DS, Wang ZQ, Wang FH, et al: Overexpression of
paxillin induced by miR-137 suppression promotes tumor progression
and metastasis in colorectal cancer. Carcinogenesis. 34:803–811.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Loedige I, Filipowicz W and Krol J: The
widespread regulation of microRNA biogenesis, function and decay.
Nat Rev Genet. 11:597–610. 2010.PubMed/NCBI
|
|
11
|
Miska EA: How microRNAs control cell
division, differentiation and death. Curr Opin Genet Dev.
15:563–568. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou C, Liu G, Wang L, Lu Y, Yuan L, Zheng
L, Chen F, Peng F and Li X: MiR-339-5p regulates the growth, colony
formation and metastasis of colorectal cancer cells by targeting
PRL-1. PLoS One. 8:e631422013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
López JA and Alvarez-Salas LM:
Differential effects of miR-34c-3p and miR-34c-5p on SiHa cells
proliferation apoptosis, migration and invasion. Biochem Biophys
Res Commun. 409:513–519. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Almeida MI, Nicoloso MS, Zeng L, Ivan C,
Spizzo R, Gafà R, Xiao L, Zhang X, Vannini I, Fanini F, et al:
Strand-specific miR-28-5p and miR-28-3p have distinct effects in
colorectal cancer cells. Gastroenterology. 142:886–896. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nishino M, Jagannathan JP, Ramaiya NH and
Van den Abbeele AD: Revised RECIST guideline version 1.1: What
oncologists want to know and what radiologists need to know. AJR Am
J Roentgenol. 195:281–289. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Uchino K, Takeshita F, Takahashi RU,
Kosaka N, Fujiwara K, Naruoka H, Sonoke S, Yano J, Sasaki H, Nozawa
S, et al: Therapeutic effects of microRNA-582-5p and −3p on the
inhibition of bladder cancer progression. Mol Ther. 21:610–619.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sakurai K, Furukawa C, Haraguchi T, Inada
K, Shiogama K, Tagawa T, Fujita S, Ueno Y, Ogata A, Ito M, et al:
MicroRNAs miR-199a-5p and −3p target the Brm subunit of SWI/SNF to
generate a double-negative feedback loop in a variety of human
cancers. Cancer Res. 71:1680–1689. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lu YX, Yuan L, Xue XL, Zhou M, Liu Y,
Zhang C, Li JP, Zheng L, Hong M and Li XN: Regulation of colorectal
carcinoma stemness, growth and metastasis by an
miR-200c-Sox2-negative feedback loop mechanism. Clin Cancer Res.
20:2631–2642. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu L, Li Y, Yan D, He J and Liu D:
MicroRNA-183 inhibits gastric cancer proliferation and invasion via
directly targeting Bmi-1. Oncol Lett. 8:2345–2351. 2014.PubMed/NCBI
|
|
20
|
Zhang N, Wang X, Huo Q, Sun M, Cai C, Liu
Z, Hu G and Yang Q: MicroRNA-30a suppresses breast tumor growth and
metastasis by targeting metadherin. Oncogene. 33:3119–3128. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li J, Kong F, Wu K, Song K, He J and Sun
W: MiR-193b directly targets STMN1 and uPA genes and suppresses
tumor growth and metastasis in pancreatic cancer. Mol Med Rep.
10:2613–2620. 2014.PubMed/NCBI
|
